The fund will be able to invest in companies all over the world, with no predetermination as to the percentages of exposure to any geographical area.
The portfolio will be diversified mainly in leading companies in the technology and health sectors. The main criteria for the selection of companies are
1. Sustained growth in sales, profits and free cash flow
3. Controlled debt
It is a 100% equity SICAV for long-term investment in those companies that benefit most from the profound socio-economic changes we are experiencing.
* Return generated in the current year, from January 1st